Biopharma Daily Stock Updates - 01/06/21

Updated: Jan 13

$XBI $143.32 (+2.04%) 📈


PIPELINE:

$IMRA (-37.97%) - Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Disease

https://imaratx.gcs-web.com/news-releases/news-release-details/imara-reports-phase-2a-clinical-trial-results-imr-687-adult


$RDHL (-3.76%) - RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease

https://ir.redhillbio.com/news-releases/news-release-details/redhill-biopharmas-rhb-204-granted-fda-fast-track-designation


$RDUS (+15.76%) - Radius Health, Inc. Announces Acquisition of Orphan Disease Program

https://ir.radiuspharm.com/news-releases/news-release-details/radius-health-inc-announces-acquisition-orphan-disease-program


$SELB (+8.22%) - Selecta Biosciences Announces Data in Non-Human Primates, FurtherValidating Multiple Potential Benefits of the ImmTORTM Platform in Gene Therapy

http://ir.selectabio.com/news-releases/news-release-details/selecta-biosciences-announces-data-non-human-primates-further


$ZNTL (-6.54%) - Zentalis Pharmaceuticals Announces the Initiation of Multiple Early-Stage Clinical Trials

https://ir.zentalis.com/news-releases/news-release-details/zentalis-pharmaceuticals-announces-initiation-multiple-early


FINANCE:

$RGNX (+8.39%) - Offering

http://ir.regenxbio.com/news-releases/news-release-details/regenxbio-announces-proposed-public-offering-common-stock-1



0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE